Frank Pieper
16Patents
10h-index
24Co-inventors
72Inventor score
Filing activity: Mar 1, 1993 → Nov 5, 2015
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5741957A | Transgenic bovine | Chemistry; Metallurgy | 260 | Expired |
| US5721367A | Homologous recombination in mammalian cells | Chemistry; Metallurgy | 240 | Expired |
| US5612205A | Homologous recombination in mammalian cells | Chemistry; Metallurgy | 226 | Expired |
| US6118045A | Lysosomal proteins produced in the milk of transgenic animals | Emerging Cross-Sectional Technologies | 90 | Expired |
| US5633076A | Method of producing a transgenic bovine or transgenic bovine embryo | Chemistry; Metallurgy | 37 | Expired |
| US8071532B2 | Use of C1 inhibitor for the prevention of ischemia-reperfusion injury | Human Necessities | 26 | Active |
| US8415288B2 | Use of C1 inhibitor for the prevention of ischemia-reperfusion injury | Human Necessities | 23 | Active |
| US6013857A | Transgenic bovines and milk from transgenic bovines | Chemistry; Metallurgy | 18 | Expired |
| US7067713B2 | C1 Inhibitor produced in the milk of transgenic non-human mammals | Human Necessities | 15 | Expired |
| US6140552A | Production of recombinant polypeptides by bovine species and transgenic methods | Chemistry; Metallurgy | 10 | Expired |
| US6066725A | Production of recombinant polypeptides by bovine species and transgenic methods | Chemistry; Metallurgy | 9 | Expired |
| US6713662B1 | Production of collagen in the milk of transgenic mammals | Chemistry; Metallurgy | 6 | Expired |
| US8557773B2 | Treatment of bleeding with low half-life fibrinogen | Chemistry; Metallurgy | 2 | Active |
| US9212215B2 | Treatment of bleeding with low half-life fibrinogen | Chemistry; Metallurgy | 1 | Active |
| US9211318B2 | Use of C1 inhibitor for the prevention of ischemia-reperfusion injury | Human Necessities | 0 | Active |
| US9962431B2 | Treatment of bleeding with low half-life fibrinogen | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.